Uttarakhand Facility :
This facility is currently operational and is WHO-GMP approved, ensuring that all production adheres to international quality standards. In the near future, we aim to secure additional global accreditations such as WHO-GENEVA, PIC/S, and EU-GMP, further enhancing our international reputation and trustworthiness.
The production capacities include:
Tablets: 2.6 Billion units per year
Capsules: 300 Million units per year
Liquids: 2.6 Million liters per year
Ointment: 30 Million per year
Gujarat Facility :
Our state-of-the-art manufacturing facility is equipped with the latest technology and equipment to ensure high-quality products that meet the standards of the WHO-GMP and PICS guidelines
The production capacities include:
Tablets: 800 Million units per year
Capsules: 400 Million units per year
Liquids: 30: Million syrup per year
Dry Powder: 30 Million per year
Ointment: 30 Million per year
Sachet: 30 Million per year
Maharashtra Facility :
Designed and constructed to comply with global standards such as WHO-GMP and PIC/S, ensuring top-notch quality and compliance. A dedicated block to foster innovation, research, and the development of new pharmaceutical formulations.
The new facility will incorporate the latest manufacturing technologies and advanced production lines to increase our capacity to meet global demand. Although final specifications may evolve as the facility progresses, the estimated production capacities are as follows:
Tablets: 800 Million units per year
Capsules: 400 Million units per year
Sachet: 30 Million per year
